Cytokinetics, Incorporated (NASDAQ:CYTK) Financings

Cytokinetics, Incorporated

Financings

RaiseDate
1.75% convertible senior notes due 2031
Made bigger: US$650M
Use of proceeds: About $402.5M to exchange 2027 convertible notes; rest for aficamten launch and development, pipeline research and general corporate purposes
Sep 16, 2025

Read by 6ix AI from the company's releases